VasoCollar Inc.
Selected as a startup company by FINDIT Matchmaking in the past two years
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
VasoCollar(Rapid Vascular Anastomosis and Blood Flow Restoration Solutions)
Founded Year
2018
Unified Business No.
42915379
Status
Active
Number of Employees
0
Total Paid-in
Capital
7,685,356 (NT$)
Location of Company
Taiwan
, Tainan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
At VasoCollar, we transform physicians' needs into innovative, standardized solutions to address critical clinical challenges—specifically, rapid vascular anastomosis and blood flow restoration. We have proof-of-concept data for 2.5 mm and 5 mm vessels in trauma and plastic surgery and have applied for four patents in the USA, China, and Taiwan since 2020. Our initial market focus is trauma, and we have secured a contract with the U.S. Department of Defense in 2014, and collaborate with Brooke Army Medical Center and Stanford Medicine in 2025. With FDA approval expected in 2026, we will launch 20 clinical trials for market entry. We are currently raising $1.5 million in angel investment to finalize product design, scale mass production, and achieve FDA approval by the end of 2026.
